Skin and Joints Podcast

PART 1: My CaSMO Playbook Managing Skin Toxicities in Oncology Treatment with Dr.Maxwell Sauder

Episode Summary

šŸŒžšŸŽ§Dermatologist Dr.Max Sauder joins us back on the podcast and navigates us through the complexities of modern dermatological carešŸ’” šŸŽ™ļø My CASMO (Canadian Skin Management in Oncology) Playbook: Part 1 šŸŽ™ļø Get ready for a laugh and learn session as Dr. Jessica Asgarpour takes the co-hosting hot seat! This episode, weā€™re diving headfirst into the CASMO project with dermo-oncologist Dr. Max Sauder. Weā€™ll decode the CASMO algorithm, tackle the nitty-gritty of managing skin toxicities, and even uncover Dr. Sauder's secret summer plans. Buckle up! šŸŽ¢ Episode Description: We're peeling back the layers of the CASMO project, an innovative approach to managing skin toxicities in cancer treatment. Can certain skin toxicities be prevented in patients? Is there a proactive skincare regimen that can be recommended for patients? 1. Introduction to CaSMO and Skin Toxicities in Cancer Treatment: Overview of the significance of managing skin toxicities, introducing the CaSMO algorithm's development and objectives. 2. Prevention Strategies: Detailed discussion on general skincare measures recommended by CaSMO, including the rationale behind the use of cleansers and moisturizers to maintain skin hydration and integrity. Episode Learning Objectives: 1. Understand the CASMO algorithm and its role in managing skin toxicities associated with cancer treatments. 2. Recognize the importance of a multidisciplinary approach in improving patient outcomes. 3. Identify practical proactive strategies for preventing and managing skin toxicities. 4. Learn about the impact of skin toxicities on patients' quality of life and how to address these issues. 5. Explore the role of various healthcare providers, including oncologists, nurses, and pharmacists, in supporting patients through their cancer journey. Press play for a dose of dermatological delight šŸŽ™ļøāœØ Episode supported by an IME Grant from LA ROCHE POSAY About Dr.Maxwell Sauder MD, FRCPC DermatologistĀ  | Toronto Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School. Dr. Sauder is currently an assistant professor at the University of Toronto.Ā He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic. Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partnerā€™s President Prize at Harvard and the Royal Collegeā€™s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions. šŸ“»www.skinandjoints.ca āœ‰ļøinfo@skinandjoints.ca

Episode Notes

šŸŒžšŸŽ§Dermatologist Dr.Max Sauder joins us and navigates us through the complexities of modern dermatological carešŸ’”

šŸŽ™ļø My CASMO (Canadian Skin Management in Oncology) Playbook: Part 1šŸŽ™ļø

Get ready for a laugh and learn session as Dr. Jessica Asgarpour takes the co-hosting hot seat! This episode, weā€™re diving headfirst into the CASMO project with dermo-oncologist Dr. Max Sauder. Weā€™ll decode the CASMO algorithm, tackle the nitty-gritty of managing skin toxicities, and even uncover Dr. Sauder's secret summer plans. Buckle up!Ā šŸŽ¢

We're peeling back the layers of the CASMO project, an innovative approach to managing skin toxicities in cancer treatment. Can certain skin toxicities be prevented in patients? Is there a proactive skincare regimen that can be recommended?

  1. Introduction to CaSMO and Skin Toxicities in Cancer Treatment:Ā Overview of the significance of managing skin toxicities, introducing the CaSMO algorithm's development and objectives.
  2. Prevention Strategies: Detailed discussion on general skincare measures recommended by CaSMO, including the rationale behind the use of cleansers and moisturizers to maintain skin hydration and integrity.

Ā 

Episode Learning Objectives:

Ā 

  1. Understand the CASMO algorithm and its role in managing skin toxicities associated with cancer treatments.
  2. Recognize the importance of a multidisciplinary approach in improving patient outcomes.
  3. Identify practical proactive strategies for preventing and managing skin toxicities.
  4. Learn about the impact of skin toxicities on patients' quality of life and how to address these issues.
  5. Explore the role of various healthcare providers, including oncologists, nurses, and pharmacists, in supporting patients through their cancer journey.

Ā 

Press play for a dose of dermatological delightĀ šŸŽ™ļøāœØ

Episode supported by an IME Grant from LA ROCHE POSAY

Ā 

REFERENCES AND FURTHER RESOURCES:

1.Ā Ā Ā Ā Ā Ā  The role of skin care in oncology patients:Ā STL-Supp-SkinCareOnc-v2-correction.pdf (skintherapyletter.com)

2.Ā Ā Ā Ā Ā Ā  Canadian general algorithm (cleanse, moisturize, protect):Canadian Skin Management in Oncology (CaSMO) Algorithm for Patients with Oncology Treatment-Related Skin Toxicities (skintherapyletter.com)

3.Ā Ā Ā Ā Ā Ā  Canadian radiotherapy algorithm:Canadian Skin Management in Oncology Group (Casmo) Algorithm for the Prevention and Management of Acute Radiation Dermatitis (skintherapyletter.com)

4.Ā Ā Ā Ā Ā Ā  Canadian immunotherapy algorithm:Ā CaSMO Management of Cutaneous Toxicities Associated with Immune Checkpoint Inhibitors: A Practical Primer (skintherapyletter.com)

5.Ā Ā Ā Ā Ā Ā  Canadian hormonal therapy algorithm:Ā Casmo Algorithm for Management of Hormonal Therapy-Related Cutaneous Adverse Effects in Oncology Patients (skintherapyletter.com)

6.Ā Ā Ā Ā Ā Ā  Canadian targeted therapy algorithm:Casmo Prevention and Management of Four Common Cutaneous Toxicities Associated with Targeted Cancer Therapies: Papulopustular Eruption, Xerosis, Paronychia, and Hand-Foot Skin Reaction (skintherapyletter.com)

Ā 

Ā 


Ā 

About Dr.Maxwell Sauder MD, FRCPC

DermatologistĀ  | Ā TorontoĀ 

Dr. Maxwell Sauder is a board-certified dermatologist with additional fellowship training. He earned his Doctor of Medicine at McMaster University and completed a residency in dermatology at The University of Ottawa. He completed fellowship training in Cutaneous Oncology at Harvard Medical School. He is a former instructor in dermatology at Harvard Medical School.

Dr. Sauder is currently an assistant professor at the University of Toronto.Ā He is an onco-dermatologist at Princess Margaret Cancer Centre. He also practices at Toronto Dermatology Centre where he is the research director and the director of the Pigmented Lesion Clinic.

Well published in numerous peer-reviewed journals, Dr. Sauder has also authored several book chapters, been referenced on www.uptodate.com, and has won numerous awards including the Partnerā€™s President Prize at Harvard and the Royal Collegeā€™s Detweiler Fellowship Award. His publications have covered topics such as eczema, patient education, aesthetic dermatology, sun safety, psoriasis, biologics, adverse drug reactions, hemangiomas, contact dermatitis, cutaneous oncology, and a host of complex medical dermatology conditions.Ā 

Ā 

šŸ“»www.skinandjoints.ca

āœ‰ļøinfo@skinandjoints.ca

Ā 

Ā